The use of crevicular fluid to assess markers of inflammation and angiogenesis, IL-17 and VEGF, in patients with solid tumors receiving zoledronic acid and/or bevacizumab.

Support Care Cancer 2019 Apr 17. Epub 2019 Apr 17.

1st Oncology Department, 'Metropolitan Hospital', 9 Ethnarxou Makariou Avenue, Piraeus, Greece.

Purpose: Crevicular fluid was used to assess interleukin-17 (IL-17) and vascular endothelial growth factor (VEGF) in cancer patients receiving zoledronic acid and/or bevacizumab. The markers were also assessed in the serum.

Methods: Twenty-five patients were included and comprised three groups: patients who received zoledronic acid (n = 9), patients who received bevacizumab (n = 9), and patients who received zoledronic acid combined with bevacizumab (n = 5). One patient received zoledronic acid and everolimus and another received zoledronic acid, bevacizumab, and temsirolimus. IL-17 and VEGF were measured by standard quantitative ELISA kits and assessed in two study points.

Results: Twenty-four patients maintained good periodontal health; one had asymptomatic osteonecrosis of the jaw. First assessment: 44 samples were collected; 21 from serum and 23 from crevicular fluid. Second assessment, 6 months later: 11 samples were collected; 6 from serum and 5 from crevicular fluid. IL-17 was detected in all samples, in serum and crevicular fluid, and remained unchanged at both time points. Serum VEGF in patients with bevacizumab alone or combined with zoledronic acid was significantly lower compared with that of patients who received zoledronic acid alone. VEGF was not detected in the crevicular fluid.

Conclusions: Crevicular fluid might be an easy, non-invasive means to assess IL-17. The stable values of IL-17 in crevicular fluid and serum and the lack of VEGF in the crevicular fluid could be related to the good periodontal health of our patients. Further studies are needed to assess IL-17 and VEGF in the crevicular fluid in patients with and without periodontal disease.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-019-04793-2DOI Listing

Still can't find the full text of the article?

We can help you send a request to the authors directly.
April 2019
2 Reads

Publication Analysis

Top Keywords

crevicular fluid
36
zoledronic acid
32
received zoledronic
20
patients received
16
serum crevicular
12
il-17 vegf
12
patients
11
crevicular
10
fluid
8
collected serum
8
fluid assess
8
and/or bevacizumab
8
zoledronic
8
n = 9 patients
8
acid
8
receiving zoledronic
8
samples collected
8
periodontal health
8
vegf crevicular
8
assess il-17
8

Similar Publications